Literature DB >> 24139908

Integrated analysis of miRNA and mRNA during differentiation of human CD34+ cells delineates the regulatory roles of microRNA in hematopoiesis.

Nalini Raghavachari1, Poching Liu2, Jennifer J Barb3, Yanqin Yang3, Richard Wang3, Quang Tri Nguyen2, Peter J Munson2.   

Abstract

In the process of human hematopoiesis, precise regulation of the expression of lineage-specific gene products is critical for multiple cell-fate decisions that govern cell differentiation, proliferation, and self-renewal. Given the important role of microRNAs (miRNAs) in development and differentiation, we examined the global expression of miRNA in CD34(+) cells during lineage specific hematopoiesis and found 49 miRNAs to be differentially expressed, with functional roles in cellular growth and proliferation, and apoptosis. miR-18a was upregulated during erythropoiesis and downregulated during megakaryopoiesis. miR-145 was upregulated during granulopoiesis and down regulated during erythropoiesis. Megakaryopoitic differentiation resulted in significant alteration in the expression of many miRNAs that are believed to play critical roles in the regulation of B and T cell differentiation. Target prediction analyses on three different miRNA databases indicated that TargetScan outperformed microCosm and miRDB in identifying potential miRNA targets associated with hematopoietic differentiation process. An integrated analysis of the observed miRNAs and messenger RNAs (mRNAs) resulted in 87 highly correlated miRNA-mRNA pairs that have major functional roles in cellular growth and proliferation, hematopoietic system development, and Wnt/B-catenin and Flt 3 signaling pathways. We believe that this study will enhance our understanding on the regulatory roles of miRNA in hematopoiesis by providing a library of mRNA-miRNA networks. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24139908      PMCID: PMC3878057          DOI: 10.1016/j.exphem.2013.10.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  50 in total

1.  Biological role of microRNA-103 based on expression profile and target genes analysis in pigs.

Authors:  Guoxi Li; Zongsong Wu; Xinjian Li; Xiaomin Ning; Yanjie Li; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2010-12-09       Impact factor: 2.316

2.  Prediction of both conserved and nonconserved microRNA targets in animals.

Authors:  Xiaowei Wang; Issam M El Naqa
Journal:  Bioinformatics       Date:  2007-11-29       Impact factor: 6.937

Review 3.  MicroRNAs: Allies or foes in erythropoiesis?

Authors:  John C H Byon; Thalia Papayannopoulou
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

4.  Transcriptome profiling and sequencing of differentiated human hematopoietic stem cells reveal lineage-specific expression and alternative splicing of genes.

Authors:  Poching Liu; Jennifer Barb; Kimberly Woodhouse; James G Taylor; Peter J Munson; Nalini Raghavachari
Journal:  Physiol Genomics       Date:  2011-08-09       Impact factor: 3.107

Review 5.  MicroRNAs as regulators of mammalian hematopoiesis.

Authors:  Chang-Zheng Chen; Harvey F Lodish
Journal:  Semin Immunol       Date:  2005-04       Impact factor: 11.130

Review 6.  MicroRNA-146a and hemopoietic disorders.

Authors:  Zhong Hua; Wang Chun; Chen Fang-Yuan
Journal:  Int J Hematol       Date:  2011-09-08       Impact factor: 2.490

Review 7.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

8.  microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.

Authors:  Yoon-Chi Han; Christopher Y Park; Govind Bhagat; Jinping Zhang; Yulei Wang; Jian-Bing Fan; Mofang Liu; Yongrui Zou; Irving L Weissman; Hua Gu
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

9.  Mir-144 selectively regulates embryonic alpha-hemoglobin synthesis during primitive erythropoiesis.

Authors:  Yan-Fang Fu; Ting-Ting Du; Mei Dong; Kang-Yong Zhu; Chang-Bin Jing; Yong Zhang; Lei Wang; Hong-Bo Fan; Yi Chen; Yi Jin; Gui-Ping Yue; Sai-Juan Chen; Zhu Chen; Qiu-Hua Huang; Qing Jing; Min Deng; Ting Xi Liu
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

10.  Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells.

Authors:  Julia E Rager; Lisa Smeester; Ilona Jaspers; Kenneth G Sexton; Rebecca C Fry
Journal:  Environ Health Perspect       Date:  2010-12-09       Impact factor: 9.031

View more
  11 in total

1.  Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach.

Authors:  Julián Candia; Srujana Cherukuri; Yin Guo; Kshama A Doshi; Jayanth R Banavar; Curt I Civin; Wolfgang Losert
Journal:  Converg Sci Phys Oncol       Date:  2015-12-21

Review 2.  Immuno-miRs: critical regulators of T-cell development, function and ageing.

Authors:  Bart-Jan Kroesen; Nato Teteloshvili; Katarzyna Smigielska-Czepiel; Elisabeth Brouwer; Anne Mieke H Boots; Anke van den Berg; Joost Kluiver
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

Review 3.  A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Int Rev Cell Mol Biol       Date:  2017-04-21       Impact factor: 6.813

4.  miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.

Authors:  Enrique Fuentes-Mattei; Recep Bayraktar; Taghi Manshouri; Andreia M Silva; Cristina Ivan; Diana Gulei; Linda Fabris; Nayra Soares do Amaral; Pilar Mur; Cristina Perez; Elizabeth Torres-Claudio; Mihnea P Dragomir; Adriana Badillo-Perez; Erik Knutsen; Pranav Narayanan; Leonard Golfman; Masayoshi Shimizu; Xinna Zhang; Wanke Zhao; Wanting Tina Ho; Marcos Roberto Estecio; Geoffrey Bartholomeusz; Ciprian Tomuleasa; Ioana Berindan-Neagoe; Patrick A Zweidler-McKay; Zeev Estrov; Zhizhuang J Zhao; Srdan Verstovsek; George A Calin; Roxana S Redis
Journal:  JCI Insight       Date:  2020-01-16

5.  Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML.

Authors:  Noah I Hornick; Jianya Huan; Ben Doron; Natalya A Goloviznina; Jodi Lapidus; Bill H Chang; Peter Kurre
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

6.  Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.

Authors:  Paola Guglielmelli; Andrea Bisognin; Claudia Saccoman; Carmela Mannarelli; Alessandro Coppe; Alessandro M Vannucchi; Stefania Bortoluzzi
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

7.  Identifying microRNA determinants of human myelopoiesis.

Authors:  Megha Rajasekhar; Ulf Schmitz; Stephane Flamant; Justin J-L Wong; Charles G Bailey; William Ritchie; Jeff Holst; John E J Rasko
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

Review 8.  The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy.

Authors:  Chengxin Luan; Zixue Yang; Baoan Chen
Journal:  Onco Targets Ther       Date:  2015-10-13       Impact factor: 4.147

9.  A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.

Authors:  E Calura; S Pizzini; A Bisognin; A Coppe; G Sales; E Gaffo; T Fanelli; C Mannarelli; R Zini; R Norfo; V Pennucci; R Manfredini; C Romualdi; P Guglielmelli; A M Vannucchi; S Bortoluzzi
Journal:  Blood Cancer J       Date:  2016-06-24       Impact factor: 11.037

10.  Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer.

Authors:  Weijia Lu; Yunyu Wu; Can Xiong Lu; Ting Zhu; Zhong Lu Ren; Zhiwu Yu
Journal:  J Ovarian Res       Date:  2020-10-01       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.